Development of a 1:1-binding biparatopic anti-TNFR2 antagonist by epitope selection https://www.biorxiv.org/content/10.1101/2022.12.15.520217v1?med=mas
Development of a 1:1-binding biparatopic anti-TNFR2 antagonist by epitope selection https://www.biorxiv.org/content/10.1101/2022.12.15.520217v1?med=mas